Hormone Replacement Therapy: Menopause
The question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to hormone replacement therapies for women experiencing the menopause.
Answered by Karin Smyth
The Government is committed to prioritising women’s health as we build a National Health Service fit for the future, and women’s equality will be at the heart of our missions. Women should not have to suffer in silence and any woman concerned about menopause symptoms should seek advice from their general practitioner or other healthcare professional, who can advise about treatment options, including hormone replacement therapy (HRT).
There are over 70 HRT products, and the vast majority are in good supply. There have been issues with the supply of a limited number of HRT products, primarily due to very sharp increases in demand, but the supply position for the majority has improved considerably over the last year.
More than 500,000 people benefitted from accessing cheaper HRT prescriptions during its first year of operation. The HRT Prescription Prepayment Certificate (PPC) can represent significant savings for patients who are prescribed one of the listed HRT medications. For example, a patient who pays the prescription charge could save nearly £220 per year with an HRT PPC, if they were prescribed two listed HRT items per month.
Verbatim has judged this answer against the question that was actually asked — answered, partly answered, or evaded. Sign in to see the verdict →